Google Scholar citation report
Citations : 14978

Journal of Basic and Clinical Pharmacy received 14978 citations as per google scholar report

Indexed In

Division of Hematology, Montefiore Medical Center of the Albert Einstein College of Medicine, New York, USA


  • Research Article   
    Safety of Direct Acting Oral Anticoagulants (DOACs) in Comparison to Enoxaparin in Gastrointestinal and Genito-Urinary Cancers
    Author(s): Shafia Rahman, Juan Trias*, Mohammad Barouqa*, Margarita Kushnir and Henny H. Billettc


    Safety of Direct Oral Anticoagulants (DOAC) in Cancer Associated Thrombosis (CAT) in patients with Gastrointestinal (GI) and Genito-Urinary (GU) malignancies is uncertain. We identified patients with active GI and GU malignancies who received either enoxaparin or a DOAC (apixaban or rivaroxaban) for CAT from July 2001 to July 2020. Demographics, disease characteristics, thrombosis data, date of anticoagulation initiation, and bleeding events at one year were recorded and analysed. We identified 206 patients, 159 received DOAC (86 apixaban; 73 rivaroxaban) and 47 enoxaparin; 128 (62.1%) and 78 (37.9%) had GI and GU malignancies, respectively. Choice of anticoagulation varied significantly based on primary malignancy. Enoxaparin was preferred in GU tumors while DOACs were preferred in GI tumors (p=0.014). Within DOACs, rivaroxaban use was higher with GI .. Read More»